INTERNATIONAL: Pharma shifts focus to emerging markets
You must be signed in to read this analysis
In this article
- Developed country business models
- Traditional impediments
- Political factors
- Image issues
- Positives and negatives
- Market presence
- High volume, low margin
- Future Western market products
- Overcoming patent concerns
- Reduced parallel sales
- High cost, low margin
- Collaboration with competitors
- Short-term gamble
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.